Oura is making a major move into AI-powered healthcare with its planned $625 million acquisition of Counsel Health, an AI-native primary care startup. The deal points to a future where wearable health insights are more directly connected to clinical support and everyday care decisions.
Oura is best known for its smart ring and health-tracking platform, which monitor signals such as sleep, recovery, and activity. By adding an AI-focused primary care company, Oura could take a step toward helping users not only understand their health data, but also act on it through more accessible care pathways.
Why this matters
- AI meets preventive health: The acquisition could help shift digital health from passive tracking toward proactive support.
- More personalized care: Wearable data may make primary care recommendations more context-aware and individualized.
- Real business momentum: A $625 million deal shows continued investor and industry confidence in practical AI healthcare applications.
The announcement also comes shortly after Oura postponed its planned IPO, citing uncertainty in the public markets. Rather than slowing down, the company appears to be using acquisition as a way to strengthen its healthcare strategy and deepen the role of AI in consumer wellness.